Selected Publications
Click for list of all "Tsilidis" publications in PubMed
Click for complete CV
1.Tsilidis KK, Papadimitriou N,
Capothanassi D,..., Boffetta P,
Trichopoulos D, Trichopoulou A. Burden of cancer in a large consortium of
prospective cohorts in Europe. J Natl Cancer Inst 2016 [accepted].
2. Dimitrakopoulou VI,
Travis RC, Shui IM,..., Kraft
P, Key TJ, Tsilidis KK. Interactions between genome-wide significant genetic
variants and circulating concentrations of 25-hydroxyvitamin D in relation to
prostate cancer risk in the NCI Breast and Prostate Cancer Cohort Consortium.
Am J Epidemiol 2016 [accepted].
3. Murphy N,
Cross AJ,
Abubakar M,...,
Tsilidis KK, Muller DC,
Riboli E,
Gunter MJ.
A Nested Case-Control Study of
Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the
European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS Med. 2016 Apr 5;13(4):e1001988.
4. Lopez DS,
Advani S, Tsilidis KK, Wang R,
Baillargeon J,
Dobs A,
Symanski E,
Canfield S.
Association of Urinary Phthalate
Metabolites With Erectile Dysfunction in Racial and Ethnic Groups in the National
Health and Nutrition Examination Survey 2001-2004. Am J Mens Health 2016 [accepted].
5. Garcia-Anguita A,
Kakourou A, Tsilidis KK. Biomarkers
of Inflammation and Immune Function and Risk of Colorectal Cancer. Curr Colorectal Cancer Rep
2015;11:250-258.
6. Sen A, Tsilidis
KK, Allen NE,..., Riboli E, Gunter M, Franceschi S. Baseline and lifetime alcohol consumption
and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer
2015;13:840-847.
7. Kakourou A,
Koutsioumpa C, Lopez DS, Hoffman-Bolton J, Bradwin G, Rifai N, Helzlsouer KJ,
Platz EA, Tsilidis KK. Interleukin-6 and risk of colorectal cancer:
results from the CLUE II cohort and a meta-analysis of prospective studies. Cancer
Causes Control 2015;26:1449-1460.
8. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis
JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of
observational studies. BMJ 2015;350:g7607.
9. Papatheodorou SI, Tsilidis
KK, Evangelou E, Ioannidis JP. Application of credibility ceilings probes the
robustness of meta-analyses of biomarkers and cancer risk. J
Clin Epidemiol 2015;68:163-74.
10. Panagiotou OA, Travis
RC, Campa D, Berndt SI, Lindstrom S, Kraft P, Schumacher FR, Siddiq A,
Papatheodorou SI, Stanford JL, Albanes D, Virtamo J, Weinstein SJ, Diver WR,
Gapstur SM, Stevens VL, Boeing H, Bueno-de-Mesquita HB, Gurrea AB, Kaaks R,
Khaw KT, Krogh V, Overvad K, Riboli E, Trichopoulos D, Giovannucci E, Stampfer
M, Haiman C, Henderson B, Le Marchand L, Gaziano JM, Hunter DJ, Koutros S,
Yeager M, Hoover RN; The PRACTICAL Consortium, Chanock SJ, Wacholder S, Key TJ,
Tsilidis KK. A
Genome-wide Pleiotropy Scan for Prostate Cancer Risk. Eur
Urol 2015;67:649-57.
11. Tsilidis KK, Capothanassi
D, Allen NE, Rizos EC, Lopez DS, van Veldhoven
K, Sacerdote C, Ashby D, Vineis P, Tzoulaki
I, Ioannidis JPA. Metformin
does not affect cancer risk: a cohort study in the UK Clinical Practice
Research Datalink analyzed like an intention-to-treat trial. Diabetes
Care 2014;37:2522-32.
12. Tsilidis KK, Allen NE, Appleby PN, Rohrmann S, Nöthlings U, Arriola L, Gunter MJ,..., Travis RC, Key TJ.
Diabetes mellitus and risk of prostate cancer in the European Prospective
Investigation into Cancer and Nutrition. Int J Cancer 2014;136:372-81.
13. Campa D, Barrdahl M, Tsilidis KK,
et al. A genome-wide pleiotropy scan does not identify new
susceptibility loci for estrogen receptor positive breast cancer. Plos
One 2013;9(2):e85955.
14. Tsilidis KK, Rohrmann
S, McGlynn KA, Nyante SJ, Lopez DS, Bradwin
G, Feinleib M, Joshu CE, Kanarek N, Nelson
WG, Selvin E, Platz EA. Association
between endogenous sex steroid hormones and inflammatory biomarkers in
US men.
Andrology 2013;1(6):919-928. Abstract
15. Tsilidis KK, Panagiotou OA, Sena ES,
Aretouli E, Evangelou E, Howells DW, Al-Shahi Salman R, Macleod MR, Ioannidis
JPA. Evaluation of excess significance bias in animal studies of neurological
diseases. Plos Biol 2013;11(7):e1001609. Abstract
16. Tsilidis KK, Travis RC, Appleby PN, Allen NE, Lindstrom S, Albanes D, et al. Insulin-like growth factor pathway genes and
blood concentrations, dietary protein, and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
Int J Cancer 2013;133:495-504. Abstract
17. Tsilidis KK, Papatheodorou SI, Evangelou E, Ioannidis JPA. Evaluation of excess statistical significance in meta-analyses of 98
biomarker associations with cancer risk. J Natl Cancer Inst 2012;105:1867-1878. Abstract
18. Tsilidis KK, Travis RC, Appleby PN, Allen NE, Lindstrom S, Schumacher FR, et al. Interactions between genome-wide
significant genetic variants and circulating concentrations of insulin-like growth factor-1, sex hormones and binding proteins in
relation to prostate cancer risk in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Am J Epidemiol 2012;
175:926-935. Abstract 19. Shinohara RT, Frangakis CF, Platz EA, Tsilidis KK. Estimating effects by combining instrumental variables with case-control
designs. Int J Biostat 2012;8(1). DOI: 10.2202/1557-4679.1355. Abstract 20. Tsilidis KK,
Allen NE, Key, TJ, et al. Oral contraceptive use and reproductive
factors and risk of ovarian cancer in the European Prospective
Investigation into Cancer and Nutrition. Br J Cancer 2011;105:1436-42. Abstract
21.Tsilidis KK, Allen NE, Key TJ, et al.
Menopausal hormone therapy and risk of ovarian cancer in the European
Prospective Investigation into Cancer and Nutrition. Cancer Causes
& Control 2011;22:1075-84. Abstract
22. Tsilidis KK, Allen NE, Key TJ, et al. Oral
contraceptives, reproductive history and risk of colorectal cancer in the
European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2010;103:1755-9. Abstract
23. Allen NE, Tsilidis KK, Key
TJ, et al. Menopausal hormone therapy and risk of
endometrial carcinoma in
postmenopausal women in the European Prospective
Investigation into Cancer and Nutrition (EPIC).
Am J Epidemiol 2010;172:1394-403. Abstract
24. Tsilidis KK, Allen NE, Key TJ,
et al. Menopausal hormone therapy and risk of colorectal cancer in the European
Prospective Investigation into Cancer and Nutrition. Int J Cancer 2011;128:1881-9. Abstract
25. Tsilidis KK, Brancati FL, Pollak MN,
Rifai N, Clipp SL, Hoffman-Bolton J, Helzlsouer KJ, Platz EA. Metabolic syndrome components and colorectal adenoma in the CLUE II
cohort. Cancer Causes Control 2010; 21:1-10. Abstract
26. Tsilidis KK, Helzlsouer
KJ, Smith MW, Grinberg V, Hoffman-Bolton J, Clipp SL, Visvanathan K, Platz EA. Association
of common polymorphisms in IL10, and in other genes related to inflammatory
response and obesity with colorectal cancer. Cancer Causes Control 2009;
20:1739-51. Abstract
27. Tsilidis KK, Branchini C, Guallar E,
Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive
protein and colorectal cancer risk: a systematic review of prospective studies.
Int J Cancer 2008; 123:1133-40. Abstract
28. Tsilidis
KK, Erlinger TP, Rifai N, Hoffman S, Hoffman-Bolton J, Helzlsouer KJ, Platz
EA. C-reactive protein and colorectal adenoma in the CLUE II cohort. Cancer
Causes Control 2008; 19: 559-67. Abstract
Articles citing my publications can be viewed via Google Scholar
|